Intrinsic Value of S&P & Nasdaq Contact Us

Bausch + Lomb Corporation BLCO NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • CA • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
$94.85
+467.6%
Analyst Price Target
$18.90
+13.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Bausch + Lomb Corporation (BLCO) has a negative trailing P/E of -16.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 21.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -6.23%, forward earnings yield 4.66%. PEG 0.68 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (71/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.68); analyst target implies upside (+13.1%).
  • Forward P/E 21.5 — analysts expect a return to profitability with estimated EPS of $0.78 for FY2026.
  • PEG Ratio 0.68 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -6.23% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.66% as earnings recover.
  • Analyst consensus target $18.90 (+13.1% upside) — modest upside expected.

Overall SharesGrow Score: 45/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
45/100
SG Score
View full scorecard →
VALUE
71/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — BLCO

Valuation Multiples
P/E (TTM)-16.0
Forward P/E21.5
PEG Ratio0.68
Forward PEG0.68
P/B Ratio0.90
P/S Ratio1.13
EV/EBITDA18.8
Per Share Data
EPS (TTM)$-1.02
Forward EPS (Est.)$0.78
Book Value / Share$18.43
Revenue / Share$14.42
FCF / Share$-0.18
Yields & Fair Value
Earnings Yield-6.23%
Forward Earnings Yield4.66%
Dividend Yield0.00%
SharesGrow IV$94.85 (+467.6%)
Analyst Target$18.90 (+13.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 9.9 0.00 0.00 1.91 -
2019 23.5 -0.40 0.70 1.85 -
2020 -388.9 3.68 0.71 2.05 -
2021 38.5 -0.03 0.75 1.86 -
2022 904.8 -9.86 0.77 1.44 -
2023 -23.0 0.01 0.87 1.44 -
2024 -20.0 -0.93 0.98 1.33 -
2025 -16.8 -1.26 0.94 1.18 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $2.03 $3.67B $710M 19.4%
2019 $0.85 $3.78B $298M 7.9%
2020 $-0.05 $3.41B $-17M -0.5%
2021 $0.52 $3.77B $182M 4.8%
2022 $0.04 $3.77B $15M 0.4%
2023 $-0.74 $4.15B $-260M -6.3%
2024 $-0.90 $4.77B $-317M -6.6%
2025 $-1.02 $5.1B $-360M -7.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.78 $0.76 – $0.84 $5.43B $5.39B – $5.44B 7
2027 $1.07 $0.95 – $1.24 $5.74B $5.65B – $5.78B 7
2028 $1.39 $1.07 – $1.63 $6.06B $6.05B – $6.06B 3
2029 $1.78 $1.76 – $1.79 $5.93B $5.88B – $5.96B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message